• LifeStance Health Group Inc LFST.OQ reported quarterly breakeven results​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of seven analysts for the quarter was for a loss of one cent per share. Wall Street expected results to range from -2 cents to -1 cents per share.

• Revenue rose 16.3% to $363.81 million from a year ago; analysts expected $355.60 million.

• LifeStance Health Group Inc's reported EPS for the quarter was breakeven results​.

• The company reported quarterly net income of $1.08 million.

• LifeStance Health Group Inc shares had risen by 13.6% this quarter and lost 15.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 40% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

• Wall Street's median 12-month price target for LifeStance Health Group Inc is $8.75, about 28.6% above its last closing price of $6.25

This summary was machine generated from LSEG data November 7 at 08:17 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)